HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanta Roychoudhury Selected Research

Nogalamycin

3/2019Induction of HRR genes and inhibition of DNMT1 is associated with anthracycline anti-tumor antibiotic-tolerant breast carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanta Roychoudhury Research Topics

Disease

36Neoplasms (Cancer)
10/2021 - 01/2004
10Squamous Cell Carcinoma of Head and Neck
01/2021 - 03/2006
9Breast Neoplasms (Breast Cancer)
11/2022 - 01/2004
8Carcinoma (Carcinomatosis)
11/2020 - 10/2006
5Carcinogenesis
10/2019 - 11/2010
4Infections
06/2018 - 03/2015
4Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2017 - 08/2009
4Colorectal Neoplasms (Colorectal Cancer)
06/2016 - 01/2011
3Lung Neoplasms (Lung Cancer)
03/2022 - 10/2019
3Lymphatic Metastasis
10/2019 - 10/2011
3Leukoplakia
11/2015 - 12/2005
3Chromosomal Instability (Chromosome Stability)
01/2015 - 05/2011
3Duodenal Ulcer (Curling's Ulcer)
03/2011 - 05/2006
3Skin Neoplasms (Skin Cancer)
07/2008 - 10/2006
2Mouth Neoplasms (Oral Cancer)
01/2021 - 03/2016
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2018 - 07/2015
2Uterine Cervical Dysplasia
01/2018 - 07/2015
2Chromosome Aberrations (Chromosome Abnormalities)
02/2015 - 07/2008
2Keratosis
07/2008 - 10/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Adenocarcinoma
01/2021
1Triple Negative Breast Neoplasms
11/2020
1Residual Neoplasm
08/2020
1Adenocarcinoma of Lung
10/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1Neoplasm Metastasis (Metastasis)
10/2017
1Ovarian Neoplasms (Ovarian Cancer)
01/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2016
1Inflammation (Inflammations)
07/2015
1Colonic Neoplasms (Colon Cancer)
05/2015
1Leukemia
09/2014
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2011

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2007
6CateninsIBA
01/2021 - 01/2011
5MicroRNAs (MicroRNA)IBA
01/2021 - 02/2015
5Codon (Codons)IBA
08/2009 - 09/2002
4ArsenicIBA
11/2020 - 10/2006
4RNA (Ribonucleic Acid)IBA
10/2019 - 01/2012
3Messenger RNA (mRNA)IBA
11/2020 - 11/2010
3Biomarkers (Surrogate Marker)IBA
10/2019 - 11/2015
3DNA (Deoxyribonucleic Acid)IBA
10/2017 - 05/2015
3Estrogens (Estrogen)FDA Link
01/2017 - 10/2011
3Progesterone Receptors (Progesterone Receptor)IBA
01/2017 - 10/2011
3Arginine (L-Arginine)FDA Link
08/2009 - 10/2006
2Transcription Factors (Transcription Factor)IBA
10/2021 - 11/2017
2Drinking WaterIBA
11/2020 - 10/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2019 - 07/2015
2AnthracyclinesIBA
03/2019 - 08/2018
2Type I DNA Topoisomerases (Topoisomerase I)IBA
08/2018 - 05/2015
2Anaphase-Promoting Complex-CyclosomeIBA
01/2015 - 01/2007
2GastrinsIBA
03/2011 - 07/2009
2Proline (L-Proline)FDA Link
08/2009 - 09/2002
2arginylprolineIBA
10/2006 - 12/2005
2Cyclin D1IBA
09/2004 - 01/2004
1Hormones (Hormone)IBA
11/2022
1Mitochondrial DNA (mtDNA)IBA
03/2022
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1CarbonIBA
01/2021
1AcetoinIBA
01/2021
1Amino AcidsFDA Link
01/2021
1Dihydrotachysterol (AT 10)IBA
01/2021
1mesoglycanIBA
01/2021
1PolymersIBA
01/2021
1Untranslated RNA (Noncoding RNA)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
03/2019
1NogalamycinIBA
03/2019
11,2,5,8-tetrahydroxy anthraquinoneIBA
08/2018
1Antineoplastic Agents (Antineoplastics)IBA
08/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Complement System Proteins (Complement)IBA
10/2017
1Topoisomerase InhibitorsIBA
02/2017
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2017
1lysophosphatidic acidIBA
01/2017
1oncolipidsIBA
01/2017
1Floxuridine (FUdR)FDA LinkGeneric
06/2016
1Cisplatin (Platino)FDA LinkGeneric
04/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2016
1SurvivinIBA
04/2016
1Cadherins (E-Cadherin)IBA
04/2016
1beta CateninIBA
01/2016
1CarcinogensIBA
11/2015
1Etoposide (VP 16)FDA LinkGeneric
07/2015
1HLA-DQB1 antigen (HLA DQB1)IBA
07/2015
1trioctyl phosphine oxide (TOPO)IBA
05/2015
1Topoisomerase II InhibitorsIBA
05/2015
1EnzymesIBA
05/2015
1Virulence Factors (Pathogenicity Factors)IBA
03/2015
1Fluorescein-5-isothiocyanate (FITC)IBA
02/2015
1Histones (Histone)IBA
02/2015
1withaferin AIBA
09/2014
1Biological ProductsIBA
05/2012
1RNA Precursors (Precursor, mRNA)IBA
11/2010
1Protein Isoforms (Isoforms)IBA
06/2010

Therapy/Procedure

6Drug Therapy (Chemotherapy)
11/2020 - 01/2013
4Therapeutics
11/2020 - 01/2013
2Neoadjuvant Therapy
01/2017 - 01/2013
1Adjuvant Chemotherapy
08/2020
1Aftercare (After-Treatment)
03/2019
1Adjuvant Radiotherapy
03/2013